ClinicalTrials.gg
Not yet recruitingNCT07874178Updated Oct 19, 2026

Temporal Interference Stimulation for Disorders of Consciousness

An interventional study of Temporal Interference in Disorder of Consciousness, Minimally Conscious State and Vegetative State, sponsored by Centre Hospitalier Universitaire de Liege. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Centre Hospitalier Universitaire de Liege · Not applicable, Interventional, and Treatment

Updated Oct 19, 2026Primary outcomes revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate whether a new non-invasive brain stimulation technique, called temporal interference stimulation, can influence brain activity and potentially improve signs of consciousness in patients with severe brain injuries and disorders of consciousness.

After a severe brain injury, some patients may remain unable to communicate or interact normally with their environment because of impaired consciousness. Current treatment options to promote recovery are limited. Temporal interference stimulation is a new technique that uses mild electrical currents applied through electrodes placed on the scalp to target specific areas deep inside the brain without surgery.

In this study, we will use brain imaging data to personalize the stimulation and target a region involved in consciousness regulation, called the thalamus. The effects of the stimulation will be evaluated using brain activity recordings, heart monitoring, and clinical assessments of consciousness and responses to stimulation.

The goal of this research is to determine whether temporal interference stimulation is safe and whether it can produce measurable changes in brain function and behavior in patients with disorders of consciousness. The results may help guide future research on new treatments for recovery after severe brain injury.

Read the detailed description

This open-label pilot study investigates the feasibility and potential neurophysiological and behavioral effects of MRI-guided temporal interference (TI) stimulation targeting the bilateral thalamus in patients with prolonged disorders of consciousness following severe acquired brain injury.

Severe brain injuries can disrupt the neural networks responsible for consciousness, particularly the interactions between the thalamus, basal ganglia, and cortical regions. The mesocircuit model suggests that impaired thalamocortical activation contributes to reduced consciousness after brain injury. While invasive approaches such as deep brain stimulation have shown potential benefits in selected patients, their clinical use is limited by surgical risks and technical constraints. Temporal interference stimulation represents a novel non-invasive neuromodulation approach designed to selectively influence deep brain structures while limiting stimulation of surrounding tissues.

During the study, individualized stimulation parameters will be determined using the patient's structural magnetic resonance imaging data. Computational modeling will be used to optimize electrode placement and electric field distribution in order to target the thalamic region. Stimulation will be delivered through transcranial electrodes placed on the scalp using two high-frequency electrical currents with slightly different frequencies. The interaction between these currents generates a low-frequency modulation at the target region, allowing selective modulation of deep neural structures.

Participants will undergo repeated TI stimulation sessions, with neurophysiological monitoring performed using high-density electroencephalography (127 electrodes) and electrocardiography before and after selected stimulation sessions. Behavioral changes associated with consciousness and responses to stimulation will be assessed using standardized clinical evaluations designed for patients with disorders of consciousness.

The study will also monitor the tolerability and safety of the intervention through continuous observation and systematic recording of potential adverse events. Previous studies of non-invasive brain stimulation techniques have demonstrated favorable safety profiles, with mainly mild and transient effects reported. This investigation aims to provide preliminary evidence regarding the capacity of temporal interference stimulation to modulate brain activity and potentially promote recovery-related changes in patients with severe disorders of consciousness.

02

Conditions studied

  • Disorder of Consciousness
  • Minimally Conscious State
  • Vegetative State
  • Unresponsive Wakefulness Syndrome
  • Brain Injury

Keywords

  • Disorders of consciousness
  • Traumatic brain injury
  • Unresponsive wakefulness syndrome
  • Minimally conscious state
  • Temporal interference stimulation
  • Non-invasive brain stimulation
  • Neurorehabilitation
03

In context

Consciousness Disorders

244 studies on the registry are indexed under Consciousness Disorders; 104 are open to participants now.

This study's planned enrollment of 4 is below the median of 44 across 155 interventional studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

Centre Hospitalier Universitaire de Liege is the lead sponsor of 39 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • Diagnosis of unresponsive wakefulness syndrome or minimally conscious state confirmed by at least two Coma Recovery Scale-Revised (CRS-R) assessments.
  • More than 28 days after the brain injury.
  • Acquired brain injury of known etiology, including: Traumatic brain injury; Isolated intracranial hemorrhage (including subarachnoid, subdural, epidural, intracerebral, or iatrogenic hemorrhage); Stroke of any etiology; Cerebral anoxia/hypoxia (e.g., following cardiac arrest, drowning, choking, or drug overdose); Other acquired brain injuries (e.g., infectious encephalitis, carbon monoxide poisoning, or chemical/solvent inhalation).
  • Available structural brain MRI.
  • Medically stable.
  • Written informed consent provided by the participant's legally authorized representative.

Exclusion criteria

Exclusion Criteria:

  • History of neurological or psychiatric disorder prior to the brain injury.
  • Pregnancy (excluded based on medical records or a pregnancy test, if applicable).
  • Presence of active brain implants and/or intracranial metallic implants.
  • Uncontrolled epilepsy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4 participants (estimated)

Study arms

  • Experimental
    Temporal Interference Stimulation

    Temporal interference stimulation is a non-invasive neuromodulation technique that uses overlapping electrical fields generated by scalp electrodes to selectively influence activity in deep brain regions.

    Device: Temporal Interference

Interventions

  • DeviceTemporal Interference

    Participants in the experimental arm will receive bilateral MRI-guided temporal interference (TI) stimulation targeting the thalami bilaterally. The stimulation will be delivered non-invasively through electrodes placed on the scalp. High-frequency electrical currents with slightly different frequencies will be applied simultaneously to generate a low- frequency modulation at the targeted brain region, allowing selective modulation of thalamic activity.

06

What researchers measure

Primary outcomes

  1. Coma Recovery Scale - revised (CRS-r)

    The Coma Recovery Scale-Revised (CRS-R, minimum score: 0; maximum score: 23, with higher scores indicating a higher level of responsiveness) is a standardized clinical assessment tool used to evaluate levels of consciousness and detect signs of recovery in patients with disorders of consciousness.

    Time frame: Immediately before and after the first stimulation session (Day 1); immediately after the third stimulation session (Day 3); Immediately before and after the last stimulation session, (Day 5); 1-week follow-up

Secondary outcomes

  1. Changes in EEG alpha-band power

    Electroencephalographic (EEG) alpha-band power will be assessed during resting-state EEG recording. An increase in alpha-band power is expected following the intervention.

    Time frame: Immediately before and after the first stimulation session (Day 1); Immediately before and after the last stimulation session (Day 5)

  2. Changes in EEG theta-band power

    Electroencephalographic (EEG) theta-band power will be assessed during resting-state EEG recording. An increase in theta-band power is expected following the intervention.

    Time frame: Immediately before and after the first stimulation session (Day 1); Immediately before and after the last stimulation session (Day 5)

  3. Changes in EEG delta-band power

    Electroencephalographic (EEG) delta-band power will be assessed during resting-state EEG recording. A decrease in delta-band power is expected following the intervention.

    Time frame: Immediately before and after the first stimulation session (Day 1); Immediately before and after the last stimulation session (Day 5)

  4. Changes in EEG spectral profile according to the ABCD model

    The EEG spectral profile will be characterized according to the ABCD model of dynamic brain states using resting-state EEG recordings to assess changes in spectral characteristics following the intervention.

    Time frame: Immediately before and after the first stimulation session (Day 1); Immediately before and after the last stimulation session

  5. Changes in alpha-band functional connectivity

    Alpha-band cortical functional connectivity will be assessed from resting-state EEG recordings using graph theory-based analyses to characterize changes in functional connectivity following the intervention

    Time frame: Immediately before and after the first stimulation session (Day 1); Immediately before and after the last stimulation session (Day 5)

  6. Heart rate

    Heart rate will be recorded using electrocardiography simultaneously to the EEG recording. Electrocardiography (ECG) is a non-invasive method used to record and assess the electrical activity of the heart. It is performed by placing electrodes on the patient's chest, allowing the measurement and visualization of heart rhythm and cardiac electrical activity over time.

    Time frame: Immediately before and after the first stimulation session (Day 1); Immediately before and after the last stimulation session (Day 5)

  7. Nociception Coma Scale-revised (NCS-r)

    The Nociception Coma Scale-Revised (NCS-R, minimum score: 0; maximum score: 9, with higher scores indicating stronger behavioral responses to nociceptive stimulation) is a standardized clinical assessment tool used to evaluate pain-related responses in patients with disorders of consciousness who are unable to communicate.

    Time frame: Baseline; Immediately after each of the 5 stimulation sessions (Day 1, 2, 3, 4 and 5)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data will be made available to qualified researchers whose requests are methodologically sound and for legitimate scientific purposes, following publication of the primary study results.

Supporting information: Study protocol

Time frame: IPD and supporting information will be made available after publication of the primary study results upon reasonable request and subject to approval.

Access criteria: Access to the anonymized individual participant data (IPD) and supporting information, including the study protocol, data dictionary, and statistical analysis code, will be granted to qualified researchers upon reasonable request.Requests will be evaluated by the principal investigator based on scientific validity, methodological quality, and compliance with the original ethical approval and informed consent.Approved users will receive access through a secure institutional repository (e.g., ULiège Dataverse)Only de- identified data will be shared.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Feb 2027, 5 months later.

Of 71 non-industry interventional studies with no phase under Consciousness Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 52. This study's planned 5 months is below that.

Counting every sponsor, half of 73 studies reached it within 29 months; a quarter within 12 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2026
First posted
Oct 14, 2026
StartEst.
Sep 2026
Primary completionEst.
Feb 2027
CompletionEst.
Feb 2027
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
primary outcomes
Registered
First appeared on the registry
Oct 14, 2026
Show all 2 updates
  1. Oct 19, 2026
    Primary outcomes Revised (3 changes)
    + 2 other changes: verification date and secondary outcomes
  2. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07874178
Lead sponsor
Centre Hospitalier Universitaire de Liege
Responsible party
Nicolas Lejeune (Professor, Centre Hospitalier Universitaire de Liege) — Principal investigator
First posted
Oct 14, 2026
Start date
Sep 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

Nicolas Lejeune
Contact
nicolas.lejeune@chuliege.be
+3243232323
Nicolas Lejeune
principal investigator · University Hospital of Liege - University of Liege
Aurore Thibaut
principal investigator · University of Liege
Fanny Montulet
study director · University of Liege

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion